Supernus Pharmaceuticals IPO Info

Company Name: Supernus Pharmaceuticals
Stock Symbol: SUPN
Exchange: NYSE
Status: Priced
IPO Date: 5/1/2012
IPO Price: 5.00 (43.60%)
Underwriters
Citi, Piper Jaffray

Amount of Offering: N/A
Number of Shares Offered: 10 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases.

SEC Filings

News Headlines